1. Cook, Stuart A. . Understanding interleukin 11 as a disease gene and therapeutic target. In The Biochemical journal, 480, 1987-2008. doi:10.1042/BCJ20220160. https://pubmed.ncbi.nlm.nih.gov/38054591/
2. Widjaja, Anissa A, Viswanathan, Sivakumar, Shekeran, Shamini G, Coffman, Thomas M, Cook, Stuart A. 2022. Targeting endogenous kidney regeneration using anti-IL11 therapy in acute and chronic models of kidney disease. In Nature communications, 13, 7497. doi:10.1038/s41467-022-35306-1. https://pubmed.ncbi.nlm.nih.gov/36470928/
3. Schafer, Sebastian, Viswanathan, Sivakumar, Widjaja, Anissa A, Sin, Kenny Y K, Cook, Stuart A. 2017. IL-11 is a crucial determinant of cardiovascular fibrosis. In Nature, 552, 110-115. doi:10.1038/nature24676. https://pubmed.ncbi.nlm.nih.gov/29160304/
4. Moon, Eui Jung, Mello, Stephano S, Li, Caiyun G, Attardi, Laura D, Giaccia, Amato J. 2021. The HIF target MAFF promotes tumor invasion and metastasis through IL11 and STAT3 signaling. In Nature communications, 12, 4308. doi:10.1038/s41467-021-24631-6. https://pubmed.ncbi.nlm.nih.gov/34262028/
5. Widjaja, Anissa A, Singh, Brijesh K, Adami, Eleonora, Schafer, Sebastian, Cook, Stuart A. 2019. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis. In Gastroenterology, 157, 777-792.e14. doi:10.1053/j.gastro.2019.05.002. https://pubmed.ncbi.nlm.nih.gov/31078624/
智鼠故事 
